Nail bed dyschromia secondary to docetaxel therapy.
Jacob
C I
CI
Patten
S F
SF
D000368:Aged; D000369:Aged, 80 and over; D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects*; D000077143:Docetaxel; D005260:Female; D006801:Humans; D009260:Nail Diseases / Q000139:chemically induced*; D017239:Paclitaxel / Q000009:adverse effects / Q000031:analogs & derivatives*; D010859:Pigmentation Disorders / Q000139:chemically induced*; D043823:Taxoids
D000972:Antineoplastic Agents, Phytogenic; D043823:Taxoids; D000077143:Docetaxel; D017239:Paclitaxel